Whales with a lot of money to spend have taken a noticeably bullish stance on Hims & Hers Health.
Looking at options history for Hims & Hers Health HIMS we detected 16 trades.
If we consider the specifics of each trade, it is accurate to state that 43% of the investors opened trades with bullish expectations and 37% with bearish.
From the overall spotted trades, 4 are puts, for a total amount of $210,245 and 12, calls, for a total amount of $1,400,840.
What's The Price Target?
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $15.0 to $43.0 for Hims & Hers Health over the recent three months.
Volume & Open Interest Trends
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Hims & Hers Health's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Hims & Hers Health's significant trades, within a strike price range of $15.0 to $43.0, over the past month.
Hims & Hers Health Option Activity Analysis: Last 30 Days
Largest Options Trades Observed:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| HIMS | CALL | TRADE | NEUTRAL | 05/16/25 | $4.45 | $4.1 | $4.25 | $38.00 | $501.5K | 2.0K | 13 |
| HIMS | CALL | TRADE | BULLISH | 01/16/26 | $21.0 | $20.7 | $21.0 | $15.00 | $417.9K | 3.2K | 632 |
| HIMS | CALL | TRADE | BULLISH | 03/14/25 | $1.25 | $1.17 | $1.25 | $35.00 | $112.3K | 935 | 3.2K |
| HIMS | PUT | SWEEP | BEARISH | 07/18/25 | $4.15 | $4.15 | $4.15 | $27.00 | $104.5K | 969 | 254 |
| HIMS | CALL | TRADE | BEARISH | 01/16/26 | $21.15 | $21.0 | $21.0 | $15.00 | $63.0K | 3.2K | 862 |
About Hims & Hers Health
Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, haircare and more.
Following our analysis of the options activities associated with Hims & Hers Health, we pivot to a closer look at the company's own performance.
Where Is Hims & Hers Health Standing Right Now?
- With a trading volume of 11,946,152, the price of HIMS is down by -1.33%, reaching $34.25.
- Current RSI values indicate that the stock is is currently neutral between overbought and oversold.
- Next earnings report is scheduled for 54 days from now.
What Analysts Are Saying About Hims & Hers Health
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $33.8.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. Click here for access. * Consistent in their evaluation, an analyst from B of A Securities keeps a Underperform rating on Hims & Hers Health with a target price of $21. * In a cautious move, an analyst from Morgan Stanley downgraded its rating to Equal-Weight, setting a price target of $60. * Maintaining their stance, an analyst from Leerink Partners continues to hold a Market Perform rating for Hims & Hers Health, targeting a price of $40. * An analyst from B of A Securities downgraded its action to Underperform with a price target of $21. * In a cautious move, an analyst from Citigroup downgraded its rating to Sell, setting a price target of $27.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Hims & Hers Health with Benzinga Pro for real-time alerts.
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
